An economic approach to clinical trial design and research priority-setting

Health Economics

Volumn 5, Issue 6, 1996, Pages 513-524

  Claxton, Karl ^a   Posnett, John ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

CEA; Clinical trials; Economic evaluation; Trial design

Indexed keywords

ARTICLE; BAYES THEOREM; BUDGET; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DECISION TREE; ECONOMICS; EPIDEMIOLOGY; HEALTH CARE PLANNING; HEALTH SERVICES RESEARCH; HUMAN; METHODOLOGY; STATISTICAL MODEL;

BAYES THEOREM; BIAS (EPIDEMIOLOGY); BUDGETS; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DECISION TREES; HEALTH PRIORITIES; HEALTH SERVICES RESEARCH; HUMANS; MODELS, ECONOMETRIC; RESEARCH DESIGN;

EID: 0030281042     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2-9     Document Type: Review

References (32)

1. Drummond, M. F. and Stoddart, G. L. Economic analysis and clinical trials. Controlled Clinical Trials 1984; 5: 115-128.
2. Bulpitt, C. J. and Fletcher, A. E. Economic assessment in randomised controlled trials. The Medical Journal of Australia 1990; 153: 16-19.
3. Drummond, M. F. and Davies, L. Economic analysis alongside clinical trials. International Journal of Technology Assessment in Health Care 1991; 7: 561-573.
4. Adams, M. E. et al. Economic analysis in randomised control trials. Medical Care 1992; 30: 231-243.
5. Schwartz, D. and Lellouch, J. Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Disease 1967; 20: 637-648.
6. Lachin, J. M. Introduction to sample size determination and power analysis for clinical trials. Controlled Clinical Trials 1981; 1: 13-28.
7. Phelps, C. E. and Mushlin, A. I. On the near equivalence of cost-effectiveness and cost-benefit analysis. International Journal of Technology Assessment in Health Care 1991; 7: 12-21
8. Laupacis, A. et al. How attractive does a new technology have to be to warrant adoption and utilisation? Tentative guidelines for using clinical and economic evaluations. Canadian Medical Association Journal 1992; 146: 473-481.
9. Berry, D. A. A case for Bayesianism in clinical trials. Statistics in Medicine 1993; 12: 1377-1393.
10. Pocock, S. J. When to stop a clinical trial. British Medical Journal 1992; 305: 235-240.
11. Spiegelhalter, D. J. and Freedman, L. S. A predictive approach to selecting the size of a clinical trial based on subjective clinical opinion. Statistics in Medicine 1986; 5: 1-13.
12. Freedman, L. S. and Spiegelhalter, D. J. Comparison of Bayesian with group sequential methods for monitoring clinical trials. Controlled Clinical Trials 1989; 10: 357-367.
13. Pocock, S. J. and Hughes, M. D. Estimation issues in clinical trials and overviews. Statistics in Medicine 1990; 9: 657-671.
14. Spiegelhalter, D. J., Freedman, L. S. and Parmar, M. K. B. Bayesian approaches to randomised trials. Journal of the Royal Statistical Society (Series A) 1994; 157: 357-416.
15. Spiegelhalter, D. J. and Freedman, L. S. Bayesian approaches to clinical trials. In Bernardo et al. (eds) Bayesian statistics, Vol. 3. Oxford: Oxford University Press, 1988: 453-477.
16. Colton, T. A two stage model for selecting one of two treatments. Journal of the American Statistical Association 1962; 58: 388-400.
17. Cornfield, J. A Bayesian test of some classical hypotheses with application to sequential clinical trials. Journal of the American Statistical Association 1966; 61: 577-594.
18. Anscombe, F. J. Sequential medical trials. Journal of the American Statistical Association 1963; 58: 365-383.
19. Whitehead, J. The design and analysis of sequential trials. Chichester: Ellis Horwood, 1992.
20. Armitage, P. Sequential medical trials. Oxford: Blackwell, 1975.
21. Armitage, P. The search for optimality in clinical trials. International Statistical Review 1985; 53: 15-24.
22. Bather, J. A. Randomised allocation of treatments in sequential experiments. Journal of the Royal Statistical Society (Series B) 1981; 43: 265-292.
23. Bather, J. A. On the allocation of treatment in sequential medical trials. International Statistical Review 1985; 53: 1-13.
24. Berry, D. A. Modified two-armed bandit strategies for certain clinical trials. Journal of the American Statistical Association 1978; 73: 339-345.
25. Raffia and Schlaifer, R. Probability and statistics for business decisions. McGraw-Hill, 1959.
26. Schlaifer, R. Introduction to statistics for business decisions. New York: McGraw-Hill, 1961.
27. Williams, A. How should information on cost influence clinical practice? In Delmothe, T. (ed.) Outcomes into Clinical Practice. London: British Medical Journal Publishing Group, 1994.
28. Buxton, M. and Hanney, S. Assessing payback from Department of Health Research and Development: Preliminary Report, Vols 1 and 2. Research Report No 19. London: Health Economics Research Group, 1994.
29. Eddy, D. Selecting technologies for assessment. International Journal of Technology Assessment in Health Care 1989; 5: 485-501.
30. Williams, J. and Anderson, D. The future of research in cardio-vascular disease. PRISM Research Report No. 1, 1993.
31. Lee, P. M. Bayesian statistics: an introduction. Oxford: Oxford University Press, 1987.
32. Williams, A. Health economics: the end of clinical freedom. British Medical Journal 1988; 297: 1183-1187.